News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,742 Results
Type
Article (13913)
Company Profile (294)
Press Release (246535)
Section
Business (79421)
Career Advice (150)
Deals (13208)
Drug Delivery (32)
Drug Development (50298)
Employer Resources (31)
FDA (5675)
Job Trends (5135)
News (144221)
Policy (10024)
Tag
Academia (914)
Alliances (21491)
Alzheimer's disease (737)
Approvals (5651)
Artificial intelligence (63)
Bankruptcy (97)
Best Places to Work (4516)
Biotechnology (242)
Breast cancer (66)
Cancer (697)
Cardiovascular disease (62)
Career advice (131)
CAR-T (57)
Cell therapy (178)
Clinical research (39821)
Collaboration (239)
Compensation (99)
COVID-19 (1002)
C-suite (68)
Cystic fibrosis (66)
Data (798)
Diabetes (73)
Diagnostics (1210)
Earnings (29001)
Events (46909)
Executive appointments (193)
FDA (5969)
Funding (249)
Gene editing (55)
Gene therapy (148)
GLP-1 (301)
Government (1064)
Healthcare (6568)
Infectious disease (1037)
Inflammatory bowel disease (94)
IPO (7196)
Job creations (862)
Job search strategy (126)
Layoffs (184)
Legal (1379)
Lung cancer (111)
Manufacturing (74)
Medical device (2566)
Medtech (2567)
Mergers & acquisitions (6113)
Metabolic disorders (225)
Neuroscience (947)
NextGen Class of 2024 (2016)
Non-profit (920)
Northern California (950)
Obesity (124)
Opinion (91)
Parkinson's disease (61)
Patents (52)
People (25009)
Pharmaceutical (49)
Phase I (14011)
Phase II (18523)
Phase III (11738)
Pipeline (324)
Postmarket research (848)
Preclinical (5933)
Radiopharmaceuticals (205)
Rare diseases (169)
Real estate (1417)
Regulatory (8207)
Research institute (933)
Southern California (867)
Startups (1966)
United States (7637)
Vaccines (159)
Weight loss (76)
Date
Today (76)
Last 7 days (453)
Last 30 days (2267)
Last 365 days (20734)
2024 (19047)
2023 (22428)
2022 (26851)
2021 (27837)
2020 (23392)
2019 (16332)
2018 (11781)
2017 (13756)
2016 (11859)
2015 (14364)
2014 (10401)
2013 (7495)
2012 (7540)
2011 (7620)
2010 (7440)
Location
Africa (146)
Asia (16848)
Australia (2838)
California (2153)
Canada (723)
China (164)
Colorado (82)
Connecticut (85)
Europe (36284)
Florida (231)
Georgia (62)
Illinois (126)
Indiana (54)
Kansas (55)
Maryland (300)
Massachusetts (1709)
Michigan (48)
Minnesota (94)
New Jersey (548)
New York (613)
North Carolina (399)
Northern California (950)
Ohio (79)
Pennsylvania (429)
South America (207)
Southern California (867)
Texas (229)
Washington State (220)
260,742 Results for "fountain therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
The fountain of youth is … a T cell?
The fountain of youth has eluded explorers for ages. It turns out the magic anti-aging elixir might have been inside us all along.
January 24, 2024
·
2 min read
Pharm Country
Bloomage Biotech receives the PCHi2023 Fountain Awards for innovation exellence
Bloomage Biotech has been awarded the prestigious Fountain Awards at the Asia-Pacific international event, PCHi, held in Guangzhou from February 15th to 17th, 2023.
March 6, 2023
·
2 min read
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Switzerland
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce its Trademark, Your Fountain of Youth, was granted protection in Switzerland by its Trademark Office.
January 30, 2023
·
5 min read
Investors Fuel Fountain of Youth Research with Longevity Company Funding
The call to develop therapeutics that interfere with aging, helping people live longer, healthier lives, is increasing—and experts say the market opportunity is high.
October 3, 2023
·
5 min read
·
Kate Goodwin
Biotech Bay
Fountain Therapeutics Congratulates Co-Founder and Executive Chairman Thomas Rando, M.D., Ph.D., for Prestigious NOMIS Distinguished Scientist Award
Fountain Therapeutics announced that Thomas Rando, M.D., Ph.D., co-founder and executive chairman of Fountain, is being honored in a ceremony held in Zurich to receive the prestigious NOMIS Distinguished Scientist Award.
October 5, 2022
·
4 min read
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Japan Patent Office issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., a trademark registration certificate for Your Fountain of Youth.
January 26, 2023
·
5 min read
Hemostemix Issued ‘Your Fountain of Youth’ Trademark by Cyprus
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Office of the Registrar of Trademarks, Republic of Cyprus, issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix Inc., a trademark registration certificate for Your Fountain of Youth.
December 8, 2022
·
5 min read
Business
Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
Fountain Therapeutics today announced the appointment of Anupama Hoey as chief business officer (CBO) effective January 17 th , 2022.
January 18, 2022
·
3 min read
Biotech Bay
Fountain Therapeutics Announces $15 Million Series A-2 Financing
Fountain Therapeutics today announced a $15 million Series A-2 financing, which brings its total Series A funding to $26 million.
November 18, 2021
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 26,075
Next
